Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 657 | $430,299,687 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 51 | 783.05 | 39,936 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 50 | 820.46 | 41,023 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 57 | 723.19 | 41,222 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 47 | 961.74 | 45,202 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 58 | 787.47 | 45,673 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 59 | 795.41 | 46,929 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 64 | 734.59 | 47,014 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 58 | 814.06 | 47,215 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 76 | 639.85 | 48,629 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 66 | 741.61 | 48,946 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 70 | 711.85 | 49,830 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 53 | 984.02 | 52,153 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 70 | 759.39 | 53,157 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 86 | 649.54 | 55,860 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 80 | 699.82 | 55,986 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 79 | 722.83 | 57,104 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 78 | 732.4 | 57,127 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 85 | 696.13 | 59,171 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 80 | 754.39 | 60,351 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 94 | 643.37 | 60,477 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 81 | 755.46 | 61,192 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 78 | 785.88 | 61,299 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 87 | 709.93 | 61,764 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 100 | 621.11 | 62,111 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 85 | 786.45 | 66,848 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 100 | 711.95 | 71,195 | D |
25 Nov 2022 13:07 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 23 Nov 2022 | Sale | 99 | 742.58 | 73,515 | D |
08 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 07 Nov 2022 | Sale | 100 | 742.79 | 74,279 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 100 | 744.01 | 74,401 | D |
25 Nov 2022 13:07 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 23 Nov 2022 | Sale | 101 | 743.66 | 75,110 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 78 | 965.51 | 75,310 | D |
10 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 08 Nov 2022 | Sale | 100 | 761.53 | 76,153 | D |
10 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 08 Nov 2022 | Sale | 100 | 765.19 | 76,519 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 119 | 645.63 | 76,830 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 99 | 788.62 | 78,073 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 109 | 718.6 | 78,327 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 110 | 712.44 | 78,368 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 99 | 794.61 | 78,666 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 103 | 811.37 | 83,571 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 113 | 784.27 | 88,623 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 95 | 945.81 | 89,852 | D |
02 Nov 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 01 Nov 2022 | Sale | 119 | 761.36 | 90,602 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 115 | 820.85 | 94,398 | D |
10 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 08 Nov 2022 | Sale | 126 | 751.23 | 94,655 | D |
08 Feb 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 07 Feb 2024 | Sale | 100 | 947.34 | 94,734 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 148 | 640.91 | 94,855 | D |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 122 | 801.16 | 97,742 | I |
15 May 2024 18:10 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 15 May 2024 | Sale | 103 | 986.57 | 101,617 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 128 | 822.67 | 105,302 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 112 | 949.07 | 106,296 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 176 | 606.78 | 106,793 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 111 | 965.69 | 107,192 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 177 | 620.11 | 109,759 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 136 | 810.38 | 110,212 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 160 | 697.29 | 111,566 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 159 | 719.72 | 114,435 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 138 | 835.67 | 115,322 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 142 | 821.4 | 116,639 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 120 | 989.14 | 118,697 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 24 Aug 2023 | Sale | 148 | 839.28 | 124,213 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 174 | 721.38 | 125,520 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 155 | 815.97 | 126,475 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 181 | 707.87 | 128,124 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 157 | 824.54 | 129,453 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 181 | 720.41 | 130,394 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 167 | 813.66 | 135,881 | D |
17 May 2024 17:57 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 17 May 2024 | Sale | 143 | 980.07 | 140,150 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 150 | 948.7 | 142,305 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 208 | 698.44 | 145,276 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 181 | 823.6 | 149,072 | D |
10 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 08 Nov 2022 | Sale | 200 | 754.7 | 150,940 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 184 | 821.46 | 151,149 | D |
10 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 08 Nov 2022 | Sale | 200 | 760.7 | 152,140 | D |
10 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 08 Nov 2022 | Sale | 200 | 763.19 | 152,638 | D |
10 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 08 Nov 2022 | Sale | 203 | 752.14 | 152,684 | D |
10 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 08 Nov 2022 | Sale | 200 | 764.23 | 152,846 | D |
10 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 08 Nov 2022 | Sale | 200 | 768.11 | 153,622 | D |
10 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 08 Nov 2022 | Sale | 201 | 766.74 | 154,115 | D |
10 Nov 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 08 Nov 2022 | Sale | 201 | 767.25 | 154,217 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 273 | 578.25 | 157,862 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 222 | 726.48 | 161,279 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 204 | 797.79 | 162,749 | D |
12 Dec 2022 16:35 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 08 Dec 2022 | Sale | 218 | 779 | 169,822 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 300 | 576.73 | 173,019 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 182 | 951.92 | 173,249 | D |
06 Jul 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 03 Jul 2023 | Sale | 250 | 710.09 | 177,522 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 182 | 987.38 | 179,703 | D |
02 Jun 2023 16:12 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Jun 2023 | Sale | 250 | 736 | 184,000 | D |
03 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Aug 2023 | Sale | 250 | 744.66 | 186,165 | D |
25 Aug 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 23 Aug 2023 | Sale | 223 | 844 | 188,212 | D |
15 Mar 2024 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Mar 2024 | Sale | 196 | 968.2 | 189,767 | D |
16 Feb 2024 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 14 Feb 2024 | Sale | 200 | 951.77 | 190,354 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 267 | 714.42 | 190,750 | D |
25 Nov 2022 13:07 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 23 Nov 2022 | Sale | 256 | 745.56 | 190,863 | D |
13 Dec 2022 16:13 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 12 Dec 2022 | Sale | 264 | 730.17 | 192,765 | D |
16 Nov 2022 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 15 Nov 2022 | Sale | 272 | 722.36 | 196,482 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 243 | 825.37 | 200,565 | D |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 254 | 800.59 | 203,350 | I |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 254 | 804.38 | 204,313 | I |
06 Sep 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Sep 2023 | Sale | 250 | 834.55 | 208,638 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)